BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8360485)

  • 1. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.
    Schadendorf D; Möller A; Algermissen B; Worm M; Sticherling M; Czarnetzki BM
    J Immunol; 1993 Sep; 151(5):2667-75. PubMed ID: 8360485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
    Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
    J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four cell-secreted cytokines act synergistically to maintain long term proliferation of human B cell lines in vitro.
    Abken H; Fluck J; Willecke K
    J Immunol; 1992 Oct; 149(8):2785-94. PubMed ID: 1328386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.
    Levy Y; Tsapis A; Brouet JC
    J Clin Invest; 1991 Aug; 88(2):696-9. PubMed ID: 1864979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
    Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
    Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro.
    Krasagakis K; Garbe C; Schrier PI; Orfanos CE
    Anticancer Res; 1994; 14(6B):2565-71. PubMed ID: 7872682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2 enhances the growth of human melanoma cells derived form primary but not from metastatic tumours.
    García-Vázquez MD; Boyano MD; Cañavate ML; Gardeazabal J; de Galdeano AG; López-Michelena T; Ratón JA; Izu R; Díaz-Ramón JL; Díaz-Pérez JL
    Eur Cytokine Netw; 2000 Dec; 11(4):654-61. PubMed ID: 11125310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes.
    Bordoni R; Fine R; Murray D; Richmond A
    J Cell Biochem; 1990 Dec; 44(4):207-19. PubMed ID: 2095366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells.
    Norgauer J; Metzner B; Schraufstätter I
    J Immunol; 1996 Feb; 156(3):1132-37. PubMed ID: 8557989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice.
    Singh RK; Gutman M; Radinsky R; Bucana CD; Fidler IJ
    Cancer Res; 1994 Jun; 54(12):3242-7. PubMed ID: 8205546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous interleukin 6 can function as an in vivo growth- stimulatory factor for advanced-stage human melanoma cells.
    Lu C; Sheehan C; Rak JW; Chambers CA; Hozumi N; Kerbel RS
    Clin Cancer Res; 1996 Aug; 2(8):1417-25. PubMed ID: 9816316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma.
    Nürnberg W; Tobias D; Otto F; Henz BM; Schadendorf D
    J Pathol; 1999 Dec; 189(4):546-51. PubMed ID: 10629556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
    Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
    Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoinduction of platelet derived growth factor (PDGF) A-chain mRNA expression in a human malignant melanoma cell line and growth inhibitory effects of PDGF-A-chain mRNA-specific antisense molecules.
    Behl C; Bogdahn U; Winkler J; Apfel R; Brysch W; Schlingensiepen KH
    Biochem Biophys Res Commun; 1993 Jun; 193(2):744-51. PubMed ID: 8512572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of interleukin 8 expression in human malignant melanoma cells.
    Singh RK; Varney ML
    Cancer Res; 1998 Apr; 58(7):1532-7. PubMed ID: 9537260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous secretion of IL-4 maintains growth and Thy-1 expression of a transformed B cell clone.
    Louie SW; Ramirez LM; Krieg AM; Maliszewski CR; Bishop GA
    J Immunol; 1993 Jan; 150(2):399-406. PubMed ID: 8093458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice.
    Mrowietz U; Schwenk U; Maune S; Bartels J; Küpper M; Fichtner I; Schröder JM; Schadendorf D
    Br J Cancer; 1999 Mar; 79(7-8):1025-31. PubMed ID: 10098731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice.
    Burch RM; Mahan LC
    J Clin Invest; 1991 Oct; 88(4):1190-6. PubMed ID: 1833422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation.
    Becker D; Lee PL; Rodeck U; Herlyn M
    Oncogene; 1992 Nov; 7(11):2303-13. PubMed ID: 1437152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma.
    Masood R; Cai J; Tulpule A; Zheng T; Hamilton A; Sharma S; Espina BM; Smith DL; Gill PS
    Clin Cancer Res; 2001 Sep; 7(9):2693-702. PubMed ID: 11555581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.